|
|
Name: |
Pennant Investors LP |
City: |
Summit |
State: |
NJ |
Zip: |
07901 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
31 |
|
View All Holdings |
Currently
Viewing:
New Positions |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
SATS |
Echostar Holding Corp |
5 |
New |
$17.35 |
$35,679,000 |
2,153,209 |
10.96% |
35,679,000 |
2,153,209 |
4.28 |
Communication Equipment |
|
ALT |
Altimmune, Inc |
10 |
New |
$7.27 |
$1,235,000 |
109,800 |
0.38% |
1,235,000 |
109,800 |
0.223 |
Diversified Investments |
|
FGEN |
Fibrogen Inc |
11 |
New |
$1.37 |
$681,000 |
768,400 |
0.21% |
681,000 |
768,400 |
0.844 |
N/A |
|
NRIX |
Nurix Therapeutics, Inc. |
12 |
New |
$0.00 |
$586,000 |
56,800 |
0.18% |
586,000 |
56,800 |
0.121 |
N/A |
|
CHRS |
Coherus Biosciences, Inc. |
13 |
New |
$2.25 |
$560,000 |
168,100 |
0.17% |
560,000 |
168,100 |
0.203 |
N/A |
|
ARQT |
Arcutis Biotherapeutics, Inc. |
14 |
New |
$7.88 |
$552,000 |
170,900 |
0.17% |
552,000 |
170,900 |
0.228 |
N/A |
|
FATE |
Fate Therapeutics Inc |
15 |
New |
$3.88 |
$546,000 |
146,100 |
0.17% |
546,000 |
146,100 |
0.123 |
Biotechnology |
|
IGMS |
Igm Biosciences, Inc. |
16 |
New |
$0.00 |
$539,000 |
64,900 |
0.17% |
539,000 |
64,900 |
0.268 |
N/A |
|
ALLK |
Allakos Inc. |
17 |
New |
$1.23 |
$508,000 |
186,100 |
0.16% |
508,000 |
186,100 |
0.218 |
N/A |
|
TVTX |
Travere Therapeutics, Inc |
18 |
New |
$6.75 |
$502,000 |
55,800 |
0.15% |
502,000 |
55,800 |
0.064 |
N/A |
|
ETNB |
89bio, Inc. |
19 |
New |
$9.37 |
$497,000 |
44,500 |
0.15% |
497,000 |
44,500 |
0.06 |
N/A |
|
ZNTL |
Zentalis Pharmaceuticals, Llc |
20 |
New |
$0.00 |
$491,000 |
32,400 |
0.15% |
491,000 |
32,400 |
0.038 |
N/A |
|
RLAY |
Relay Therapeutics, Inc. |
21 |
New |
$6.74 |
$467,000 |
42,400 |
0.14% |
467,000 |
42,400 |
0.031 |
N/A |
|
RCUS |
Arcus Biosciences Inc |
22 |
New |
$15.56 |
$453,000 |
23,700 |
0.14% |
453,000 |
23,700 |
0.037 |
N/A |
|
MGNX |
Macrogenics Inc |
23 |
New |
$16.05 |
$421,000 |
43,800 |
0.13% |
421,000 |
43,800 |
0.071 |
Biotechnology |
|
ARCT |
Arcturus Therapeutics Ltd |
24 |
New |
$6.94 |
$413,000 |
13,100 |
0.13% |
413,000 |
13,100 |
0.053 |
N/A |
|
ALLO |
Allogene Therapeutics, Inc. |
25 |
New |
$0.00 |
$412,000 |
128,400 |
0.13% |
412,000 |
128,400 |
0.092 |
N/A |
|
MCRB |
Seres Therapeutics, Inc. |
26 |
New |
$1.11 |
$409,000 |
292,300 |
0.13% |
409,000 |
292,300 |
0.236 |
N/A |
|
ZYME |
Zymeworks Inc |
27 |
New |
$9.12 |
$402,000 |
38,700 |
0.12% |
402,000 |
38,700 |
0.061 |
N/A |
|
AGEN |
Antigenics Inc |
28 |
New |
$0.44 |
$389,000 |
469,600 |
0.12% |
389,000 |
469,600 |
0.215 |
Biotechnology |
|
SAGE |
Sage Therapeutics, Inc. |
29 |
New |
$0.00 |
$379,000 |
17,500 |
0.12% |
379,000 |
17,500 |
0.03 |
N/A |
|
ERAS |
Erasca, Inc. |
30 |
New |
$2.18 |
$354,000 |
166,200 |
0.11% |
354,000 |
166,200 |
0.137 |
N/A |
|
AGIO |
Agios Pharmaceuticals Inc |
31 |
New |
$32.80 |
$336,000 |
15,100 |
0.1% |
336,000 |
15,100 |
0.022 |
N/A |
|
ENTA |
Enanta Pharmaceuticals Inc |
32 |
New |
$13.10 |
$330,000 |
35,100 |
0.1% |
330,000 |
35,100 |
0.175 |
Biotechnology |
|
QURE |
uniQure B.V. |
33 |
New |
$4.82 |
$328,000 |
48,500 |
0.1% |
328,000 |
48,500 |
0.109 |
N/A |
|
CMPX |
Compass Therapeutics Ord Shs |
35 |
New |
$0.00 |
$310,000 |
199,000 |
0.1% |
310,000 |
199,000 |
0.203 |
N/A |
|
NVAX |
Novavax Inc |
36 |
New |
$0.36 |
$289,000 |
60,300 |
0.09% |
289,000 |
60,300 |
0.051 |
Biotechnology |
|
REPL |
Replimune Group Inc |
37 |
New |
$6.88 |
$257,000 |
30,500 |
0.08% |
257,000 |
30,500 |
0.054 |
N/A |
|
BTAI |
Bioxcel Therapeutics Inc |
38 |
New |
$2.35 |
$248,000 |
83,900 |
0.08% |
248,000 |
83,900 |
0.344 |
N/A |
|
ALVR |
Allovir Inc |
39 |
New |
$0.80 |
$147,000 |
215,700 |
0.05% |
147,000 |
215,700 |
0.35 |
N/A |
|
BLUE |
Bluebird Bio, Inc. |
40 |
New |
$1.01 |
$121,000 |
87,400 |
0.04% |
121,000 |
87,400 |
0.085 |
Biotechnology |
|